Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain PTHN message board posts where the ticker symbol PTHN has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest PTHN SEC Filings

Filings Format Description Filing Date File/Film Number
15-12B  Documents Securities registration termination [Section 12(b)]
Acc-no: 0001104659-17-056944 (34 Act)  Size: 24 KB
2017-09-13 001-37837
171083101
SC 13D/A  Documents [Amend] General statement of acquisition of beneficial ownership
Acc-no: 0001104659-17-056941 (34 Act)  Size: 100 KB
2017-09-13 005-89586
171083028
SC 14D9/A  Documents [Amend] Solicitation, recommendation statements
Acc-no: 0001104659-17-056895 (34 Act)  Size: 24 KB
2017-09-13 005-89586
171082265
SC TO-T/A  Documents [Amend] Tender offer statement by Third Party
Acc-no: 0001104659-17-056894 (34 Act)  Size: 76 KB
2017-09-13 005-89586
171082263
SC 13D  Documents General statement of acquisition of beneficial ownership
Acc-no: 0001104659-17-056123 (34 Act)  Size: 115 KB
2017-09-07 005-89586
171074222
8-K  Documents Current report, items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, and 9.01
Acc-no: 0001104659-17-055475 (34 Act)  Size: 51 KB
2017-09-05 001-37837
171068933
25  Documents Notification of the removal from listing and registration of matured, redeemed or retired securities
Acc-no: 0001104659-17-055224 (34 Act)  Size: 17 KB
2017-09-01 001-37837
171066651
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-050950 Size: 11 KB
2017-08-31
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-050949 Size: 8 KB
2017-08-31
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-050948 Size: 16 KB
2017-08-31
More PTHN SEC Filings


Related news from
Wed, 30 Aug 2017
14:15:02 +0000
Thermo Fisher Acquires Patheon, Boosts Laboratory Products
Thermo Fisher's (TMO) acquisition of Patheon significantly strengthens its Pharmaceutical and Biotech business by adding complementary services.
Tue, 29 Aug 2017
13:15:00 +0000
DSM Informs Market on Patheon N.V.
HEERLEN, Netherlands , August 29, 2017 /PRNewswire/ -- Royal DSM, a global science-based company active in health, nutrition and materials, informs its stakeholders that Thermo Fisher Scientific Inc. has ...
Tue, 29 Aug 2017
12:55:00 +0000
Thermo Fisher Scientific Completes Acquisition of Patheon
WALTHAM, Mass., Aug. 29, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO), the world leader in serving science, announced that it has completed its acquisition of Patheon N.V. (PTHN), a leading contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. Today's close follows the expiration of Thermo Fisher's initial tender offer for Patheon at $35.00 per share in cash. "We're pleased to complete our acquisition of Patheon and look forward to the significant value this transaction will create for our customers and our shareholders," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific.
Thu, 24 Aug 2017
13:24:01 +0000
Thermo Fisher's Patheon Buyout Gains Antitrust Clearance
Thermo Fisher (TMO) gets antitrust clearance to move a step closer toward completion of Patheon acquisition.
Wed, 23 Aug 2017
20:05:00 +0000
Thermo Fisher Scientific Announces Receipt of All Required Regulatory Approvals for Proposed Acquisition of Patheon
WALTHAM, Mass., Aug. 23, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO), the world leader in serving science, announced that all required antitrust clearances have been obtained for the previously announced all-cash tender offer by its wholly owned subsidiary, Thermo Fisher (CN) Luxembourg S.à r.l., to purchase all of the outstanding ordinary shares of Patheon N.V. (PTHN). Competition authorities in Brazil approved the transaction on August 7, 2017, initiating a 15 calendar-day comment period, which expired on August 22, 2017. Additionally, the European Commission approved the transaction today.
Tue, 22 Aug 2017
20:45:00 +0000
Patheon Announces Intent to Voluntarily Delist from the NYSE Subject to and Conditioned upon the Initial Expiration of the Tender Offer and Acquisition of Shares by Thermo Fisher
Patheon N.V., a public limited liability company organized under the laws of The Netherlands , today announced that it has submitted written notice to the New York Stock Exchange of its intention to voluntarily delist its ordinary shares, par value €0.01 per share , from the NYSE.
Thu, 10 Aug 2017
23:08:00 +0000
Thermo Fisher Scientific Prices Offering of Senior Notes
Thermo Fisher intends to use all of the net proceeds of the offering to fund a portion of the consideration payable for its acquisition of Patheon N.V. (PTHN), including the repayment of indebtedness of Patheon N.V. to be assumed by Thermo Fisher. As previously announced, Thermo Fisher now expects to complete the transaction around the end of the third quarter of 2017, subject to the satisfaction of customary closing conditions, including the receipt of applicable regulatory approvals and completion of Thermo Fisher's tender offer to acquire all of the issued and outstanding shares of Patheon N.V.
Wed, 09 Aug 2017
02:40:00 +0000
Thermo Fisher Scientific Prices Offering of Common Stock
WALTHAM, Mass., Aug. 8, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO) announced that it has priced its underwritten public offering of 8,771,930 shares of common stock at a price of $171.00 per share for expected gross proceeds of approximately $1.5 billion, before the underwriting discount and expenses. Thermo Fisher has also granted the underwriters a 30-day option to purchase up to an additional 1,315,789 shares of its common stock. Thermo Fisher intends to use all of the net proceeds of the offering to fund a portion of the consideration payable for its acquisition of Patheon N.V. (PTHN), including the repayment of indebtedness of Patheon N.V. to be assumed by Thermo Fisher.
Mon, 07 Aug 2017
20:15:00 +0000
Thermo Fisher Scientific Announces $1.5 Billion Offering of Common Stock
WALTHAM, Mass., Aug. 7, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO) announced that it has commenced an underwritten public offering of $1.5 billion of its common stock. Thermo Fisher also intends to grant the underwriters an option for a period of 30 days to purchase up to $225.0 million of additional shares of its common stock. All of the shares in the offering are to be sold by Thermo Fisher.
Mon, 07 Aug 2017
20:14:00 +0000
Thermo Fisher Extends Cash Tender Offer for All Outstanding Shares of Patheon to Coordinate Offer Timing with Two Remaining Regulatory Approvals
WALTHAM, Mass., Aug. 7, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO), the world leader in serving science, announced that its wholly owned subsidiary, Thermo Fisher (CN) Luxembourg S.à r.l., has extended the offering period of its previously announced all-cash tender offer to purchase all of the outstanding ordinary shares of Patheon N.V. (PTHN). The tender offer is being extended to coordinate with the timing of the two remaining regulatory approvals in the European Union and Brazil. In Brazil, competition authorities approved the transaction today, initiating a 15 calendar-day comment period (which is expected to expire August 22).
Thu, 29 Jun 2017
16:00:00 +0000
Patheon to Invest $45 Million, Expanding Capabilities to Support Continued Growth
Patheon N.V. , a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical sector, today announced that it expects to invest approximately $45 million at key sites across its global network to meet growing customer demand for expanded service capabilities.
Wed, 28 Jun 2017
12:15:00 +0000
Earnings Review and Free Research Report: Patheon's Q2 Results Topped Estimates; To be Acquired by Thermo Fisher
LONDON, UK / ACCESSWIRE / June 28, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Patheon N.V. (NYSE: PTHN ), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=PTHN ...
Fri, 23 Jun 2017
16:39:00 +0000
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Patheon N.V. - PTHN
BALA CYNWYD, PA / ACCESSWIRE / June 23, 2017 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Patheon N.V. ("Patheon" ...
Wed, 21 Jun 2017
13:40:00 +0000
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Patheon N.V. to Thermo Fisher Scientific Inc. is Fair to Shareholders
The following statement is being issued by Levi & Korsinsky, LLP:
Wed, 14 Jun 2017
17:44:00 +0000
Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Patheon N.V. - PTHN
NEW YORK , June 14, 2017 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York ...
Tue, 13 Jun 2017
15:56:00 +0000
PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria
After acquiring Amsterdam-based Patheon, TMO will continue its focus on collecting future companies into its back pocket.
Thu, 08 Jun 2017
10:50:44 +0000
Patheon Holdings tops Street 2Q forecasts
On a per-share basis, the Amsterdam-based company said it had profit of 19 cents. Earnings, adjusted for one-time gains and costs, were 20 cents per share. The results exceeded Wall Street expectations. ...
Thu, 08 Jun 2017
10:30:00 +0000
Patheon Reports Fiscal 2017 Second Quarter
Patheon N.V. , a leading global provider of pharmaceutical development and manufacturing services, today reported financial results for the quarter ended April 30, 2017.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is the gold standard, valuable because of the exceptional people who post here, and because the best of them are candid, detailed and informed. There is little tolerance for the b.s. found on public boards, and management and members are vigilant and aggressive about TOS violations. VF is the gold standard." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards